Kyung-Oh Kim

11PUBLICATIONS
125CO-AUTHORS
PharmacogenomicsEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesInter-organisational, extra-organisational and global information systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory Drugs.

|Jun 10, 2026
Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance.

|Jan 16, 2026
Randomized, Double-Blind, Active-Controlled, Parallel, Phase 3 Clinical Trial for Evaluating the Efficacy and Safety of Zastaprazan in Patients with Gastric Ulcers.

Kyung Sik Park, Hyun-Soo Kim, Jung-Hwan Oh

|Sep 05, 2025
Superior Efficacy of Bismuth-Containing Rifabutin Quadruple Therapy over Rifabutin Triple Therapy as Salvage Treatment.

Hannah Lee, Jun-Won Chung, Kyoung Oh Kim

|Jun 13, 2023
Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study.

Jie-Hyun Kim, Hwoon-Yong Jung, In Kyung Yoo

|Jul 06, 2022
Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial.

Yoon Jin Choi, Yong Chan Lee, Jung Mogg Kim

Pageof 2

Frequent Collaborators

5 joint publications

Jun-Won Chung

4 joint publications

Moo In Park

4 joint publications

Byung-Wook Kim

4 joint publications

Yoon Jae Kim